netFormulary Coventry and Warwickshire Area Prescribing Committee NHS
Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (0,0)
06.01.01.01 Short-acting insulins (1,0)
06.01.01.02 Intermediate- and long-acting insulins (10,0)
Biphasic insulins (3,0)
06.01.01.03 Hypodermic equipment (0,0)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (2,5)
06.01.02.02 Biguanides (2,0)
06.01.02.03 Other antidiabetic drugs (4,7)
DPP-4 inhibitors (3,0)
Alpha glucosidase inhibitors (0,0)
GLP-1 mimetics (6,0)
SGLT2 inhibitors (0,0)
Meglitinides (0,0)
Other (0,0)
Thiazolidinediones (0,1)
Glucagon-like peptide-1 receptor agonists - once weekly (0,0)
06.01.02.07 Other antidiabetic drugs (0,0)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (0,0)
Chronic hypoglycaemia (1,0)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
Diabetic nephropathy (0,0)
Diabetic neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,0)
Blood glucose monitoring (0,0)
Urinalysis (1,0)
Oral glucose tolerance test (0,0)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (3,2)
06.02.02 Antithyroid drugs (3,0)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (3,4)
Disadvantages of corticosteroids (0,0)
Use of corticosteroids (0,0)
Pregnancy and breastfeeding (0,0)
Administration (0,0)
Withdrawal of corticosteroids (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones and their modulators (0,0)
06.04.01.01 Oestrogens and HRT (0,0)
Hormone replacement therapy (0,0)
Ethinylestradiol (1,0)
Raloxifene (2,0)
Oestrogen only tablets (0,0)
Oestrogens and progestogen sequential combined therapy (0,0)
Continuous combined therapy (0,0)
Gonadomimetic (0,0)
Selective oestrogen modulator (0,0)
06.04.01.02 Progestogens (1,2)
06.04.02 Male sex hormones and antagonists (2,0)
Anti-androgens (2,1)
06.04.03 Anabolic steroids (1,1)
06.04.04 Gender dysphoria (0,0)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (2,0)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,1)
Anti-oestrogens (2,0)
Anterior pituitary hormones (10,0)
Hypothalmic hormones (1,0)
06.05.02 Posterior pituitary hormones and antagonists (0,0)
Posterior pituitary hormones (3,0)
Antidiuretic hormone antagonists (2,0)
06.06 Drugs affecting bone metabolism (0,0)
Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (3,0)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,2)
Bisphosphonates (8,4)
Denosumab (2,0)
Strontium renelate (0,1)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (3,0)
06.07.02 Drugs affecting gonadotrophins (3,0)
Gonadorelin analogues (12,0)
Breast pain (mastalgia) (0,0)
06.07.03 Metyrapone (1,0)
06.07.04 Somatomedins (1,0)
netFormulary